Abstract
We evaluated 113 pediatric patients with chronic hepatitis C from 2009 to 2019 at a Brazilian tertiary center. Seventy patients received pegylated-interferon treatment. The sustained virologic response was 61.4%, and 92.8% reported side effects. Currently, we are following 39 patients with chronic hepatitis C, 24 of whom are eligible for treatment with direct-acting antivirals according to Brazilian recommendations.
Author supplied keywords
Cite
CITATION STYLE
Hirsch, C. B., Pereira, M. F. B., Benevides, G. N., Bernardes, T. M., Palandri, G. G., Bastos, K. L. D. M., … Marques, H. H. D. S. (2020). Hepatitis C in Children and Adolescents of a Brazilian Tertiary Center: Identifying Patients Eligible for Direct-Acting Antivirals. Pediatric Infectious Disease Journal, 39(9), E276–E278. https://doi.org/10.1097/INF.0000000000002725
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
